Novo Nordisk Share Split 2024. Novo nordisk has announced its latest trial result for the new obesity drug, cagrisema, which disappointed investors and sent its share price plunging 20% in denmark. Pharmaceutical heavyweight novo nordisk (nyse:

Discover historical prices for nvo stock on yahoo finance. The most recent stock split occurred on september 20th, 2023.